Previous Article | Next Article ![]()
Journal of Virology, January 2001, p. 952-960, Vol. 75, No. 2
Enterovirus Laboratory, National Public
Health Institute (KTL), FIN-00300 Helsinki, Finland
Received 8 May 2000/Accepted 16 October 2000
We have studied coxsackievirus A9 (CAV9) mutants that each have a
single amino acid substitution in the conserved 29-PALTAVETGHT-39 motif
of VP1 and a reduced capacity to produce infectious progeny virus.
After uncoating, all steps in the infection cycle occurred according to
the same kinetics as and similar efficiency to the wild-type virus.
However, the particle/infectious unit ratio in the progeny was
significantly increased. The differences were apparently due to altered
stability of the capsid: there were mutant viruses with enhanced or
hindered uncoating, and both of these characteristics were found to
reduce fitness under standard passaging conditions. At 32°C the
instable mutants had an advantage, while the wild-type and the most
stable mutant grew poorly. When comparing the newly published CAV9
structure and the other enterovirus structures, we found that the
PALTAVETGHT motif is always in exactly the same position, in a cavity
formed by the 3 other capsid proteins, with the C terminus of VP4
between this motif and the RNA. In the 7 enterovirus structures
determined to date, the most conserved residues of the studied motif
have identical contacts to neighboring residues of VP2, VP3, and VP4.
We conclude that (i) the mutations affect the uncoating step necessary
for infection, resulting in an untimely or hindered externalization of
the VP1 N terminus together with the VP4, and (ii) the reason for the
studied motif being evolutionarily conserved is its role in maintaining
an optimal balance between the protective stability and the functional
flexibility of the capsid.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.952-960.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Coxsackievirus A9 VP1 Mutants with Enhanced or
Hindered A Particle Formation and Decreased Infectivity
*
Corresponding author. Present address: Centro de
Biología Molecular "Severo Ochoa," Universidad Autonoma de
Madrid, 28049 Madrid, Spain. Phone: (34-91) 3978 477. Fax: (34-91) 3974 799. E-mail: airaksinen{at}cbm.uam.es.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|